DOCSLIB.ORG

Scientific Council Dinner PRESENTING the KLERMAN & FREEDMAN AWARDS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Council Dinner PRESENTING the KLERMAN & FREEDMAN AWARDS BRAIN & BEHAVIOR RESEARCH FOUNDATION Scientific Council Dinner PRESENTING THE KLERMAN & FREEDMAN AWARDS FRIDAY, JULY 27, 2018 METROPOLITAN CLUB NEW YORK 1 Welcome to the Scientific Council Dinner 24th ANNUAL KLERMAN PRIZE where we will present the 2018 Klerman FOR EXCEPTIONAL CLINICAL RESEARCH & Freedman Awards. Albert R. Powers III, M.D., Ph.D. The Scientific Council, led by its founding President, Dr. Herbert Pardes, review Yale University School of Medicine and select the most promising research ideas with the greatest potential to lead to further breakthroughs. We thank them for their time, expertise, and HONORABLE MENTION judgement to support the mission of the Foundation. Tonight we will recognize and honor the exceptional work of some of the out- Timothy Y. Mariano, M.D., Ph.D., MSc standing researchers who have received awards through the Brain & Behavior Harvard Medical School Research Foundation’s Young Investigator Grant program, which supports Brigham and Women’s Hospital young scientists as they gather pilot data and “proof of concept” for their Butler Hospital innovative clinical and basic research. The Prizes are named for Gerald L. Klerman and Daniel X. Freedman, two neuro- psychiatry pioneers who played seminal roles as researchers, teachers, physicians and administrators. Their outstanding contributions continue to inspire scientists st who knew them, as well as those who are just entering the field. The prizewinners 21 ANNUAL FREEDMAN PRIZE are selected by committees of the Foundation’s Scientific Council. FOR EXCEPTIONAL BASIC RESEARCH Five young researchers are being recognized tonight for their work in psychosis, non-invasive brain stimulation to treat chronic back pain which can often lead Byungkook Lim, Ph.D. to depression and anxiety, stress induced depression and autism spectrum University of California, San Diego disorders, memory disorders and adaptive decision making that goes awry in mental illness. HONORABLE MENTIONS Following dinner, Dr. Pardes will lead an engaging discussion on the state of research and psychiatry with select members of our Scientific Council. Christina Gremel, Ph.D. The Brain & Behavior Research Foundation continues to support the most University of California, San Diego promising ideas in brain research across disciplines, institutions and continents. We hope that as you learn about the achievements of this evening’s honorees Ueli Rutishauser, Ph.D. they will inspire your continued support of our work toward a future in which all Cedars-Sinai Medical Center, Los Angeles people living with a psychiatric condition lead full, productive, and happy lives. Sincerely, Jeffrey Borenstein, M.D. President & CEO 2 3 KLERMAN KLERMAN THE KLERMAN PRIZE Prizewinners Honorable Mentions 1995 Dr. Rajiv Tandon 1995 Dr. Elizabeth D. Abercrombie The Klerman Prize, established in 1994 by Myrna M. Weissman, Ph.D., in Dr. Kim T. Mueser memory of her late husband, Gerald L. Klerman, M.D., honors exceptional 1996 Dr. Hans C. Brieter Dr. Jose V. Pardo clinical research by a Young Investigator Grantee. 1997 Dr. Schahram Akbarian 1996 Dr. Steven E. Arnold Dr. Helen S. Mayberg A distinguished psychiatric researcher and mentor at the National Institute of 1998 Dr. Michael Maes 1997 Dr. Andrew J. Francis Mental Health (NIMH) and a member of the faculties of Yale, Harvard and 1999 Dr. Andrew L. Stoll Dr. Katharine A. Phillips Cornell Universities, Dr. Klerman served from 1977 to 1980 as chief administrator 1998 Dr. Cameron S. Carter at the Alcohol, Drug Abuse and Mental Health Administration. 2000 Dr. Susan K. Schultz Dr. Mark R. Serper At the NIMH, Dr. Klerman became a central figure in the psychopharmacology 2001 Dr. Cameron S. Carter 1999 Dr. Shitij Kapur service center’s collaborative study of phenothiazine as a treatment for acute Dr. Josephy R. Hibbeln Dr. Brian F. O’Donnell schizophrenia and in the program on the psychobiology of depression. He led Dr. Sarah H. Lisanby 2000 Dr. Mark S. George planning of multi-site studies defining affective and anxiety disorders as well as Dr. Perry F. Renshaw Dr. Sohee Park the development and evaluation of treatments. 2002 Dr. E. Sherwood Brown 2002 Dr. Stephan Heckers Dr. John W. Newcomer Dr. Anissa Abi Dargham While pioneering studies of psychotropic medications, he developed and Dr. Jeffrey H. Meyer tested interpersonal psychotherapy, a treatment now used throughout 2003 Dr. Ramin Mojtabai Dr. Yvette I. Sheline the world. 2004 Dr. Helen Link Egger 2003 Dr. Catherine Monk Dr. Gerard Sanacora Dr. Weissman is herself an eminent depression researcher at Columbia Dr. Joan L. Luby 2005 Dr. Anne L. Glowinski University and the New York State Psychiatric Institute. She has received 2005 Dr. Melissa P. DelBello Dr. Gerard Sanacora three Distinguished Investigator Grants and the Brain & Behavior Research 2006 Dr. Hilary P. Blumberg 2006 Dr. Stephan Eliez Foundation 1994 Outstanding Achievement Prize in Mood and Affective Dr. Jordan W. Smoller Disorders (renamed The Colvin Prize in 2012). In 2013, she joined the 2007 Dr. Beng-Choon Ho 2007 Dr. Yuval Y. Neria Foundation’s Scientific Council. 2008 Dr. Gabriel Alejandro Dr. Carolyn M. Salafia de Erausquin 2011 Dr. Brian M. D’Onofrio Dr. Jennifer S. Silk 2009 Dr. Alina Suris 2012 Dr. Johanne Renaud KLERMAN PRIZE SELECTION COMMITTEE 2010 Dr. Daniel P. Dickstein Dr. Manpreet Kaur Singh Dr. Mani N. Pavuluri 2013 Dr. Daniel Mueller 2011 Dr. Chadi Calarge Dr. Andrea Danese Responsible for selecting the Klerman MEMBERS Prizewinners, the following Foundation Martin B. Keller, M.D. 2012 Dr. Jess G. Fiedorowicz 2014 Dr. Mazen A. Kheirbek Dr. Bo Li Scientific Council Members make up Brown University the Selection Committee: 2013 Dr. James McPartland 2015 Dr. Chadi Abdallah Rachel G. Klein, Ph.D. Dr. Carrie J. McAdams 2014 Dr. Denis Jabaudon CHAIR New York University 2016 Dr. Erin C. Dunn Robert M.A. Hirschfeld, M.D. 2015 Dr. Alan Anticevic Nina R. Schooler, Ph.D. Dr. Avram Holmes Well Cornell Medical College, State University of New York, Downstate 2016 2017 Dr. Danai Dima Cornell University Dr Katie McLaughlin Karen Dineen Wagner, M.D., Ph.D. Dr. Carolyn Rodriguez 2017 Dr. Jennifer C. Felger University of Texas Medical Branch at Galveston 04 05 2018 Albert R. Powers III, M.D., Ph.D. is an Assistant Professor at KLERMAN the Yale University Department of Psychiatry and Medical Director of the PRIME Psychosis Research Clinic at Yale. PRIZEWINNER In addition to treating patients who suffer from the earliest symp- FOR EXCEPTIONAL CLINICAL RESEARCH toms of psychosis, he uses computational approaches to under- stand how sensory systems might go awry to produce hallucinations and other psychotic symptoms. As a graduate student, Dr. Powers studied multisensory integration, or the process by which the brain combines information from the different senses into a meaningful representation of the world around us. In particular, he focused upon the ability of this process to change with perceptual learning. He found that audiovisual integration is capable of far more flexibility than was previously thought, and that the changes in behavior accompanying that flexibility are accompanied by robust brain network “ The work I have completed changes. Together these findings carry implications for treatment approaches for would simply not have been disorders in which these processes may be possible without my 2015 Young abnormal, such as schizophrenia, autism, Investigator Award. Together and dyslexia. we have laid the foundation for Dr. Powers applied this background in even more fundamental dis- sensory neuroscience to a study conducted coveries as our understanding with Yale researcher Philip Corlett, Ph.D. Aided by a Young Investigator grant, their of the computational under- work resulted in the first evidence for a pinnings of psychosis grows. computational model of hallucinations. Receiving the Klerman Award is While completing this work, Dr. Powers an incredible honor because of completed his psychiatric training, spending most of his outpatient time at its storied history and impres- the cutting-edge Specialized Treatment sive roster of past awardees, Early in Psychosis (STEP) Clinic, where he but most of all because it learned team-based care for first-episode represents the esteem of my Albert R. Powers III, M.D., Ph.D. psychosis and gained a passion for caring Assistant Professor of Psychiatry for this patient population. colleagues for the work I have been able to accomplish with Yale University Dr. Powers received his B.A. from Yale University in 2004, and his Ph.D. and M.D. the support of the BBRF.” from Vanderbilt University School of 2015 Young Investigator Grant Medicine in 2012. 06 07 Timothy Mariano, M.D., Ph.D., M.Sc. is an Instructor of Psychiatry at Harvard Medical School and an Associate Psychiatrist at 2018 Brigham and Women’s Hospital. KLERMAN PRIZE Dr. Mariano’s research interests and clinical work focus on HONORABLE MENTION neuromodulation, or the electromagnetic stimulation of brain and other nerve cells to modify their activity. Dr. Mariano studies a type of noninvasive brain stimulation called transcranial direct current stimulation (tDCS) as a potential treatment for the emotional symptoms of chronic low back pain. Chronic low back pain is a disabling and costly disease, substantially burdening patients, families, and the health care system. Estimates suggest it may affect 15 percent to 45 percent of individuals. The emotional symptoms—or “suffering” aspect—of chronic low back pain underlies much of the syndrome’s disability and reduced quality of life, and the can lead to associated psychiatric disorders such as anx- iety, depression—and even suicide. Current pain-relieving treatments do not address these emotional symptoms, and medications such as prescription opioids often provide only short-term relief while having serious side effects including addiction and overdose deaths. In Dr. Mariano’s lab, researchers have carried out preliminary studies using tDCS “ My Young Investigator Grant came to determine how the treatment may impact emotional symptoms of pain and to determine as I was navigating the critical the technique’s safety in treating chronic low transition from psychiatry trainee back pain.
Load more

Recommended publications
  • Preliminary Program Dopamine 2016, Vienna, Austria Monday, September
    Last Update: May. 2, 2016. Preliminary Program Dopamine 2016, Vienna, Austria Monday, September 5th 09:00 Registration 11:00 Opening Remarks, Welcome Addresses 11:15 Plenary Lecture 1: Chair: Antonello Bonci (NIDA-IRP, Baltimore, USA) Introduction 11:20 Karl Deisseroth (Stanford University, USA) Title to be announced 12:15 Short lunch break 13:00 Parallel Symposium 1: Thinking locally, acting globally: novel mechanisms for regulation of the response characteristics of dopamine neurons Chair: Susan G Amara (NIMH, USA) Co-Chair: Aurelio Galli (Vanderbilt Kennedy Center, Nashville, USA) Introduction 13:10 Speaker 1: Suzanne M Underhill, (NIMH, USA) Regulated trafficking of dopamine and glutamate transporters: a mechanism for signal integration by dopamine neurons 13:35 Speaker 2: Susan L. Ingram (Oregon Health & Science University, USA) Amphetamine increases dopamine neuron NMDA-GluN2B synaptic currents involved in locomotor stimulation 14:00 Speaker 3: Sweyta Lohani (University of Pittsburgh, USA) Modulation of prefrontal cortex and striatal networks by VTA dopamine neurons 14:25 Speaker 4: Andrew Yee (Physiology, Centre for Brain Res, University of Auckland, New Zealand) Activity-dependence of dopamine release from the somato-dendritic region of nigral dopaminergic neurons 13:00 Parallel Symposium 2: Functional diversity of dopamine signalling in the mammalian brain Chair: Stephan Lammel, (University of California, Berkeley, USA), Co-Chair: Robert Malenka (Stanford University, USA) Introduction 13:10 Speaker 1: Robert Malenka (Stanford
    [Show full text]
  • Pioneering Solutions for Depression and Bipolar Disorder the Stanford Mood Disorders Center
    Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center Campaign for Stanford Medicine We are all part of the equation. “Never before have we been so close to breakthroughs that will transform our approach to mood disorders, delivering advanced solutions for sufferers, their families, their friends, and their communities. Stanford is leading the way in understanding brain processes and transforming new knowledge, rapidly and efficiently, into new therapies and technologies.” Alan F. Schatzberg, MD THE KENNETH T. NORRIS, JR. PROFESSOR AND CHAIR EMERITUS, STANFORD DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center One out of five Americans will experience some form of mood disorder in their lifetime—such as depression or bi- polar disorder. Despite their prevalence, mood disorders remain one of the most widespread, misunderstood, and stigmatized health issues we face. Their impact reverber- ates far beyond an individual’s life. Families, friends, com- munities, economies—all are affected by these diseases. By 2020, depression will rank second in morbidity among all illnesses worldwide; bipolar disorder will rank fifth. Tragically, suicide, often triggered by a mood disorder, takes more than one million lives worldwide every year. Although the incidence and impact of mood disorders are undeniably on the rise, hope for solutions has never been higher. Through the Stanford Mood Disorders Center and Research Program, scientists and physicians are building on Stanford’s traditions of excellence, healing, and innovation. They are leveraging new knowledge of genetics and the brain’s molecular processes, and drawing on new techniques for imaging and healing the brain.
    [Show full text]
  • Sunderland Society Feb 27 2018
    NEW DEVELOPMENTS ON THE HORIZON S U N D E R L A N D S O C I E T Y M E E T I N G A I N R O F I L A C , D R O F N A T S 8 1 0 2 , 6 - 3 H C R A M Welcome 23rd Annual Sunderland Society Meeting Dear Sunderland Members and Guests: It is with great pleasure and gratitude that Dr. Gary Steinberg and I welcome you to Stanford for the 23rd meeting of the Sunderland Society. We want to honor its namesake, Sir Sydney Sunderland, and his commitment to pursuing excellence in the science, art, and clinical practice of peripheral nerve surgery. The theme of the scientific program, “new developments on the horizon”, emphasizes and encourages the process of taking new ideas and techniques from the laboratory bench into the clinical arena. This theme epitomizes Stanford’s mission: “research informs leading edge clinical care to promote the public welfare.” Stanford is not only an institution of academic excellence, but also houses numerous artistic treasures in the Cantor Arts Center, which contains one of the largest collections of Rodin sculptures, and the Anderson Museum that focuses on modern art. Stanford is also an athletic powerhouse as evidenced by its large number of Olympic and star athletes, as well as its world-class athletic facilities. We look forward to sharing and enjoying these wonderful resources and experiences with you, and hope that you leave intellectually invigorated and emotionally charged. Sincerely, Gary K Steinberg, MD, PhD Michel Kliot, MD Chairman President Department of Neurosurgery Clinical Professor Stanford University
    [Show full text]
  • MAP Directory of Award Recipients and Board Members
    MAP Directory of Award Recipients and Board Members Abul K. Abbas, MBBS Visiting Professor - Pfizer Visiting Professorships in Allergic Diseases and Asthma (2001) Awarded Institution: Creighton University School of Medicine Visiting Professor Host: Thomas B. Casale , MD (Creighton University School of Medicine) Francois M. Abboud, MD Board Member - ACCF/Pfizer Career Development Awards in University of Iowa Clinical or Preventive Cardiovascular Medicine (2000 - 2004) Iowa City, IA Board Member - ACCF/Pfizer Postdoctoral Fellowship Awards in Cardiovascular Medicine (2000 - 2004) Visiting Professor Host - Pfizer Visiting Professorships in Allergic Diseases and Asthma (1997) Awarded Institution: University of Iowa Visiting Professor: Jack A. Elias , MD (Yale University) Visiting Professor - ACCF/Pfizer Visiting Professorships in Preventive Cardiovascular Medicine (1986) Awarded Institution: Medical College of Virginia Visiting Professor Host: Hermes A. Kontos , MD, PhD (Medical College of Virginia) Sponsor - Pfizer Fellowships - Postdoctoral - Various Areas (1985) Awarded Institution: Awardee: Brian D. Miller , MD Evan Dale Abel, MD, PhD The University of Utah School of Medicine Visiting Professor Host - Pfizer Visiting Professorships in Salt Lake City, UT Diabetes (2010) Awarded Institution: The University of Utah School of Medicine Visiting Professor: Clay F Semenkovich , MD (Washington University in St. Louis School of Medicine) Visiting Professor Host - Pfizer Visiting Professorships in Obesity (2009) Awarded Institution: The University
    [Show full text]
  • Sunday, March 29
    Motivational Circuits in Natural and Learned Behaviors Sunday, March 29 3:00 pm Check-in 6:00 pm Reception (Lobby) 7:00 pm Dinner 8:00 pm Welcome and Opening Remarks 8:05 pm Session 1 Chair: Scott Sternson 8:05 pm Wolfram Schultz, University of Cambridge The dopamine reward signal codes economic utility 8:30 pm Nora Volkow, National Institute on Drug Abuse/NIH DA role in sustaining effort by engaging prefrontal circuits and disengaging default mode network and how these systems get disrupted in addiction 8:55 pm Refreshments available at Bob’s Pub NOTE: Meals are in the Dining Room Talks are in the Seminar Room Posters are in the Lobby 3/27/15 Motivational Circuits in Natural and Learned Behaviors Monday, March 30 7:30 am Breakfast (service ends at 8:45am) 9:00 am Session 2 Chair: Ron Stoop 9:00 am Naoshige Uchida, Harvard University Arithmetic of dopamine reward prediction errors 9:25 am Patricia Janak, Johns Hopkins University Parsing the role of dopamine neurons in learning and performance 9:50 am Joshua Dudman, Janelia Research Campus/HHMI The vigorous pursuit of reward 10:15 am Break 10:45 am Session 3 Chair: Gul Dolen 10:45 am Howard Fields, University of California, San Francisco Mesocorticolimbic mediation of learned appetitive behaviors: A circuit analysis 11:10 am Kent Berridge, University of Michigan Affective neuroscience of reward and motivation: Liking, wanting, dread and disgust 11:35 pm Jeffrey Friedman, Rockefeller University Radiowave control of feeding and glucose metabolism 12:00 pm Bernardo Sabatini, HHMI/Harvard
    [Show full text]
  • Self-Study of Graduate Education
    Self-Study of Graduate Education Curriculum in Neurobiology School of Medicine University of North Carolina, Chapel Hill Submitted to: The Graduate School University of North Carolina, Chapel Hill April 2012 1 Dr. William D. Snider Director of the UNC Neuroscience Center and the Neurobiology Curriculum Dr. Aldo Rustioni Associate Director, Neurobiology Curriculum Denise E. Kenney Student Services Manager 2 Site Visit Committee May 15-17th 2012 Committee Chair: Professor Louis Reichardt, University of California, San Francisco Committee Members: Professor Carol Mason, Columbia University, New York Professor Henrik Dohlman, UNC/Biochemistry and Biophysics (Internal reviewer) 3 TABLE OF CONTENTS PROGRAM OVERVIEW pages A. Mission, Goals and Objectives 7 B. Faculty 8 C. Students 8 D. Research Environment 8 E. Self-Study 9 CURRICULUM 9 A. Degree Requirements: Doctoral 9 Required Course Work 10 Examinations and Dissertation Guidance Committees 10 B. Degree Requirements: Master 12 C. Advising/Mentoring 13 FACULTY 14 A. Research Interests 15 B. Faculty by Year 16 C. Affiliations 16 D. Titles 17 E. Publications in high-impact journals 17 F. Grant Support 18 STUDENTS 19 A Admission, Current Students and Their Advisor 19 B. Research Interests 21 C. First Author Publications 22 D. Financial Support 22 E. Teaching Experience 22 F. GRE Scores 23 4 INTELLECTUAL ENRICHMENT 23 THE FUTURE 25 A. Continued Neuroscience Faculty Recruitment 25 B. Improved Student Recruitment 25 C. Course Curriculum 25 D. Fund Raising 26 E. Challenges 26 -------------- . ---------------
    [Show full text]